The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. (2013)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1124/mol.113.087783

PubMed Identifier: 23979972

Publication URI: http://europepmc.org/abstract/MED/23979972

Type: Journal Article/Review

Volume: 84

Parent Publication: Molecular pharmacology

Issue: 5

ISSN: 0026-895X